Antibody Persistence at the Population Level 5 Years After Mass Vaccination With Meningococcal Serogroup A Conjugate Vaccine (PsA-TT) in Burkina Faso: Need for a Booster Campaign?
Clin Infect Dis
; 68(3): 435-443, 2019 01 18.
Article
in En
| MEDLINE
| ID: mdl-30481265
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Mass Vaccination
/
Meningococcal Vaccines
/
Neisseria meningitidis, Serogroup A
/
Meningococcal Infections
/
Antibodies, Bacterial
Type of study:
Observational_studies
/
Prevalence_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Adult
/
Animals
/
Child
/
Child, preschool
/
Female
/
Humans
/
Infant
/
Male
Country/Region as subject:
Africa
Language:
En
Journal:
Clin Infect Dis
Journal subject:
DOENCAS TRANSMISSIVEIS
Year:
2019
Type:
Article
Affiliation country:
Burkina Faso